Back to NATIXIS NATIXIS

INBXINBX

Showing 7 of 8 quarters

Position history for NATIXISNATIXIS's holdings in INHIBRX BIOSCIENCES INC

No. Natixis exited its INBX (Inhibrx Biosciences) position in Q1 2026. Its Q4 2025 13F listed 889 shares worth $70,231. Natixis already held INBX in its Q2 2024 13F, the earliest on record, and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$31,320

Total Shares Change

-2,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$74.33
0
2025-Q4
Decreased
889
-55.5%
$70,2310.0%$77.98
0
2025-Q3
Unchanged
2,000
0.0%
$67,3600.0%$32.31
0
2025-Q2
Unchanged
2,000
0.0%
$28,5400.0%$14.43
0
2025-Q1
Unchanged
2,000
0.0%
$27,4800.0%$14.12
0
2024-Q4
Unchanged
2,000
0.0%
$30,8000.0%$15.14
0
2024-Q3
Unchanged
2,000
0.0%
$31,3200.0%$15.52
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used